Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lenhard

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 4, 2020
Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic ControlEmily C Soriano, James M Lenhard, Jeffrey S Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaS A Kliewer, S S Sundseth, S A Jones, et al.
Anticancer Research|July 31, 2012
Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancerN Ditsch, A Vodermaier, A Hinke, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Journal of the American Society of Nephrology : JASN|March 20, 2009
Regulatory allospecific T cell clones abrogate chronic allograft rejectionAna Maria Waaga-Gasser, Martin R Grimm, Jens Lutz, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IVCurt D Haffner, Darryl L McDougald, Steven M Reister, et al.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Journal of Medicinal Chemistry|January 12, 2011
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agentsRaymond J Patch, Lily L Searle, Alexander J Kim, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 4, 2020
Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic ControlEmily C Soriano, James M Lenhard, Jeffrey S Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaS A Kliewer, S S Sundseth, S A Jones, et al.
Anticancer Research|July 31, 2012
Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancerN Ditsch, A Vodermaier, A Hinke, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Journal of the American Society of Nephrology : JASN|March 20, 2009
Regulatory allospecific T cell clones abrogate chronic allograft rejectionAna Maria Waaga-Gasser, Martin R Grimm, Jens Lutz, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IVCurt D Haffner, Darryl L McDougald, Steven M Reister, et al.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Journal of Medicinal Chemistry|January 12, 2011
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agentsRaymond J Patch, Lily L Searle, Alexander J Kim, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
Pageof 8